Renal osteodystrophy is common in patients with chronic kidney disease and end-stage
renal disease and leads to the risks of fracture and extraosseous vascular calcification …

Chronic kidney disease mineral and bone disorder (MBD) encompasses changes in mineral
ion and vitamin D metabolism that are widespread in the setting of chronic kidney disease …

Chronic kidney disease mineral bone disorder (CKD-MBD) is common in end-stage renal
disease and is associated with an increased risk of cardiovascular morbidity and mortality …

The objective of this study was to determine the impact of calcium sensing receptor (CASR)
A990G genetic polymorphism on parathyroid hormone (PTH) lowering response to …

The binding of drugs to DNA plays a critical role in new drug discovery and is important for
designing better drugs. In this study, the interaction and binding mode of calf-thymus double …

Abstract Purposes of Review With chronic kidney disease (CKD) progression, secondary
hyperparathyroidism (sHPT) and mineral and bone metabolism disease (MBD) almost …

Context Chronic kidney disease (CKD) causes multiple interrelated disturbances in mineral
metabolism. Genetic studies in the general population have identified common genetic …

Introduction: Secondary hyperparathyroidism (SHPT) represents a complication of chronic
kidney disease (CKD). Vitamin D system is altered since early CKD, and vitamin D …

Rationale to reduce calcium intake in patients with CKD - PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …

Calcium is the most abundant metabolite involved in the stone matrix. The CaSR gene
controls calcium homeostasis, and genetic variation in the CaSR gene could lead to the …